Factors Affecting Cervical Cancer Screening Uptake by Hmong Hilltribe Women in Thailand

  • Published : 2014.04.30


Background: Cervical cancer is relatively common in Thai women, but the proportion of females receiving Pap smear screening is still low. Objective: The purpose of this cross-sectional study was to study factors related to cervical cancer screening uptake by Hmong hilltribe women in Lomkao District, Phetchabun Province. Materials and Methods: Interview data were collected from 547 of these women aged 30-60 years living in the study area and analyzed using multiple logistic regression. Results: The results showed that 64.9% of the study sample had received screening, and that 47.2% had attended due to a cervical screening campaign. The most common reason given for not receiving screening was lack of time (21.4%). The factors found to be positively associated with uptake (p value <0.05) were as follows: number of years of school attendance (OR=1.56, 95%CI:1.02-2.38), animistic religious beliefs (OR=0.55, 95%CI:0.33-0.91), a previous pregnancy (OR=6.20, 95%CI:1.36-28.35), receipt of information about cervical cancer screening (OR=2.25, 95%CI:1.35-3.76), and perceived risk of developing cervical cancer (OR=1.83, 95%CI:1.25-2.67). Conclusions: To promote the uptake of cervical screening, Hmong hilltribe women need to know more about cervical cancer and cervical cancer screening, and access to screening services should be provided in conjunction with existing everyday services, such as family planning and routine blood pressure monitoring or diabetes services.



  1. Boonpongmanee C, Jittanoon P (2007). Predictors of Papanicolaou testing in working women in Bangkok, Thailand. Cancer Nurs, 30, 384-9.
  2. Bray F, Ren JS, Masuyer E, Ferlay J (2013). Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer, 132, 1133-45.
  3. Chan C, Ho SC, Chan SG, et al (2002). Factors affecting uptake of cervical and breast cancer screening among perimenopausal women in Hong Kong. Hong Kong Med, 8, 334-41.
  4. Ferlay J, Soerjomataram I, Ervik M, et al (2013). GLOBOCAN 2012: Cancer incidence and mortality worldwide. IARC Cancer Base No. 11, Lyon, France.
  5. Gan DE, Dahlui M (2013). Cervical screening uptake and its predictors among rural women in Malaysia. Singapore Med J, 54, 163-8.
  6. Gyenwali D, Pariyar J, Onta SR (2013). Factors associated with late diagnosis of cervical cancer in Nepal. Asian Pac J Cancer Prev, 14, 4373-7.
  7. Jontasopeepun P, Davidson PM, Srisomboon J (2012). Issues and challenges in implementing cervical cancer screenings in the emergence of HPV vaccination in Thailand. Collegian, 19, 45-50.
  8. Kasinpila C, Promthet S, Vatanasapt P, Sasieni P, Parkin DM (2011). Evaluation of the nationwide cervical screening programme in Thailand: a case-control study. J Med Screen, 18, 147-53.
  9. Khamankar ST, Belekar V, Bhagat VM, Baviskar SR (2014). Cervical cancer screening: risk factors for cervical neoplasia among rural women of nanded maharashtra. Innovative J Med & Health Sci, 4, 312-6.
  10. Khuhaprema T, Attasara P, Srivatanakul P, et al (2012). Organization and evolution of organized cervical cytology screening in Thailand. Int J Gynaecol Obstet, 118, 107-11.
  11. Kritpetcharat O, Wutichouy W, Sirijaichingkul S, Kritpetcharat P (2012). Comparison of Pap smear screening results between Akha hill tribe and urban women in Chiang Rai province, Thailand. Asian Pac J Cancer Prev, 13, 5501-4.
  12. Lee GY (2005). The shaping of traditions: agriculture and Hmong society. Hmong Stud J, 6, 1-33.
  13. Lemoine J (2008). To tell the truth. Hmong Stud J, 9, 1-29.
  14. Lemoine J (2011). Commentary: the (H)mong shamans' power of healing: sharing the esoteric knowledge of a great Mong shaman. Hmong Stud J, 12, 1-36.
  15. Lyimo FS, Beran TN (2012). Demographic, knowledge, attitudinal, and accessibility factors associated with uptake of cervical cancer screening among women in a rural district of Tanzania: three public policy implications. BMC Public Health, 12, 22.
  16. Munoz N, Franceschi S, Bosetti C, et al (2002). Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet, 359, 1093-101.
  17. Nene B, Jayant K, Arrossi S, et al (2007). Determinants of womens participation in cervical cancer screening trial, Maharashtra, India. Bull World Health Organ, 85, 264-72.
  18. Peirson L, Fitzpatrick-Lewis D, Ciliska D, Warren R (2013). Screening for cervical cancer: a systematic review and metaanalysis. Syst Rev, 2, 35.
  19. Shekhar S, Sharma C, Thakur S, Raina N (2013). Cervical cancer screening: knowledge, attitude and practices among nursing staff in a tertiary level teaching institution of rural India. Asian Pac J Cancer Prev, 14, 3641-5.
  20. Scheppers E, van Dongen E, Dekker J, Geertzen J, Dekker J (2006). Potential barriers to the use of health services among ethnic minorities: a review. Fam Pract, 23, 325-48.
  21. Sriamporn S, Khuhaprema T, Parkin DM (2006). Cervical cancer screening in Thailand: an overview. J Med Screen, 13, 39-43.
  22. Considerations for cervical cancer screening: a narrative review for the U.S. Preventive Services Task Force. Ann Intern Med, 155, 698-705.
  23. Wang Y, Yu YH, Shen K, et al (2014). Cervical cancer screening and analysis of potential risk factors in 43,567 women in Zhongshan, China. Asian Pac J Cancer Prev, 15, 671-6.
  24. Wong YL, Chinna K, Mariapun J, et al (2013). Correlates between risk perceptions of cervical cancer and screening practice. Prev Med, 57, 24-6.
  25. Yang RC, Mills PK, Dodge JL (2006). Cancer screening, reproductive history, socioeconomic status, and anticipated cancer-related behavior among Hmong adults. Asian Pac J Cancer Prev, 7, 79-85.
  26. Yang, K (2008). A visit to the Hmong of Asia: globalization and ethnicity at the dawn of the 21st century. Hmong Stud J, 9, 1-50.

Cited by

  1. Preliminary Evaluation of the in vitro Efficacy of 1, 2-di (Quinazolin-4-yl) Diselane against SiHa Cervical Cancer Cells vol.15, pp.15, 2014,
  2. Effects of an Educational Intervention Based on the Protection Motivation Theory and Implementation Intentions on First and Second Pap Test Practice in Iran vol.15, pp.17, 2014,
  3. Challenges of Providing Cervical Cancer Prevention Programs In Iran: A Qualitative Study vol.15, pp.23, 2015,
  4. Proximity of Health Care Center and Cervical Cancer Screening Uptake in Thailand vol.16, pp.7, 2015,
  5. Personal and Socio-Cultural Barriers to Cervical Cancer Screening in Iran, Patient and Provider Perceptions: a Qualitative Study vol.16, pp.9, 2015,
  6. Knowledge, Attitudes and Behavior of Bangkok Metropolitan Women Regarding Cervical Cancer Screening vol.17, pp.3, 2016,
  7. Assessment of community health volunteers’ knowledge on cervical cancer in Kadibo Division, Kisumu County: a cross sectional survey vol.17, pp.1, 2017,
  8. Exploring health services accessibility by indigenous women in Asia and identifying actions to improve it: a scoping review pp.1465-3419, 2018,